Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations

被引:0
|
作者
H. K. Stulzer
P. O. Rodrigues
T. M. Cardoso
J. S. R. Matos
M. A. S. Silva
机构
[1] Universidade Federal de Santa Catarina,Department of Science Pharmacy
[2] Universidade de São Paulo,Department of Elementar Chemistry, Chemistry Institute
关键词
captopril; compatibility; FTIR; thermoanalytical techniques; X-ray powder diffraction;
D O I
暂无
中图分类号
学科分类号
摘要
Captopril (CAP) was the first commercially available angiotensine-converting enzyme (ACE) inhibitor. In the anti-hypertensive therapy is considered the selected drug has to be therapeutically effective together with reduced toxicity. CAP is an antihypertensive drug currently being administered in tablet form. In order to investigate the possible interactions between CAP and excipients in tablets formulations, differential scanning calorimetry (DSC) and thermogravimetric (TG) analysis completed by X-ray powder diffraction (XRPD) and Fourier transform infrared spectroscopy (FTIR) were used for compatibility studies. A possible drug-excipient interaction was observed with magnesium stearate by DSC technique.
引用
收藏
页码:323 / 328
页数:5
相关论文
共 50 条
  • [1] Compatibility studies between captopril and pharmaceutical excipients used in tablets formulations
    Stulzer, H. K.
    Rodrigues, P. O.
    Cardoso, T. M.
    Matos, J. S. R.
    Silva, M. A. S.
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2008, 91 (01) : 323 - 328
  • [2] Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations
    Lira, A. M.
    Araujo, A. A. S.
    Basilio, I. D. J.
    Santos, B. L. L.
    Santana, D. P.
    Macedo, R. O.
    THERMOCHIMICA ACTA, 2007, 457 (1-2) : 1 - 6
  • [3] Compatibility studies between piroxicam and pharmaceutical excipients used in solid dosage forms
    Stulzer H.K.
    Tagliari M.P.
    Cruz A.P.
    Silva M.A.S.
    Laranjeira M.C.M.
    Pharmaceutical Chemistry Journal, 2008, 42 (4) : 215 - 219
  • [4] Evaluation of Pharmaceutical Compatibility between Acarbose and Common Excipients Used in the Development of Controlled Release Formulations
    Gholizadeh-Hashjin, Aiesheh
    Shabani, Mohammad
    Monajjemzadeh, Farnaz
    PHARMACEUTICAL SCIENCES, 2021, 27 (03) : 399 - 406
  • [5] Compatibility studies between propafenone and selected excipients used in the development of controlled release formulations
    Shahe, Mahammad S.
    Chetty, Madhusudhana
    Murthy, K. V. Ramana
    ASIAN JOURNAL OF PHARMACEUTICS, 2012, 6 (02) : 144 - 150
  • [6] COMPATIBILITY STUDIES OF INDAPAMIDE/PHARMACEUTICAL EXCIPIENTS USED IN TABLET PREFORMULATION
    Rus, Lucia Maria
    Tomuta, Ioan
    Iuga, Cristina
    Maier, Codruta
    Kacso, Irina
    Borodi, Gheorghe
    Bratu, Ioan
    Bojita, Marius
    FARMACIA, 2012, 60 (01) : 92 - 101
  • [7] Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations
    Verma, RK
    Garg, S
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (03) : 449 - 458
  • [8] Thermal Compatibility of New ACEI Derivatives with Popular Excipients Used to Produce Solid Pharmaceutical Formulations
    Broncel, Mateusz
    Juszczak, Anna
    Szczolko, Wojciech
    Silvestri, Daniele
    Bialek-Dratwa, Agnieszka
    Waclawek, Stanislaw
    Kowalski, Oskar
    Ramos, Pawel
    PHARMACEUTICALS, 2024, 17 (10)
  • [9] Compatibility study between chitosan and pharmaceutical excipients used in solid dosage forms
    M. A. V. Pereira
    G. D. Fonseca
    A. A. Silva-Júnior
    M. F. Fernandes-Pedrosa
    M. de F. V. de Moura
    E. G. Barbosa
    A. P. B. Gomes
    K. S. C. R. dos Santos
    Journal of Thermal Analysis and Calorimetry, 2014, 116 : 1091 - 1100
  • [10] Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms
    Tita, Bogdan
    Fulias, Adriana
    Bandur, Geza
    Marian, Eleonora
    Tita, Dumitru
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 56 (02) : 221 - 227